Posted on 26/10/05
Canadian generic-drug firm plans to copy Tamiflu
Apotex Inc., Canada's biggest maker of generic drugs, has begun preliminary work on a synthetic copy of Tamiflu in case the country faces an avian influenza pandemic."We'll know in six to eight weeks whether we have a viable project," company president Jack Kay said. "Then it's going to take us anywhere from eight to 12 months before we have a product to submit" to health regulators in Ottawa.
The full text of this article has 335 words.
To continue reading this article, you will need to purchase this article.
Already have a member account? Login now
Pay-Per-View Offers To read the complete article, select one of the following options
Purchasing from globeandmail.com is quick and secure.
